Vitamin K Dosing for Warfarin-Associated Intracerebral Hemorrhage
Give vitamin K 10 mg intravenously as a single dose immediately, concomitantly with PCC administration. 1
Rationale and Evidence Base
The Neurocritical Care Society and Society of Critical Care Medicine 2016 guidelines provide a strong recommendation with moderate quality evidence for administering vitamin K to ensure durable INR reversal in warfarin-associated intracranial hemorrhage 1. This is critical because:
- PCC provides rapid but temporary reversal (onset within 15-60 minutes), while vitamin K ensures sustained anticoagulation reversal over 12-24 hours as warfarin's effect continues
- Without vitamin K, patients risk rebound elevation of INR after PCC's clotting factors are consumed or metabolized
- The combination significantly reduces mortality: guideline-concordant administration of both PCC and vitamin K within 8 hours was associated with a two-fold decrease in 7-day mortality (OR 2.15) in all bleeding patients and a three-fold decrease (OR 3.23) specifically in intracranial hemorrhage 2
Dosing Algorithm
Initial dose:
- Vitamin K 10 mg IV given as soon as possible or simultaneously with PCC 1
- Route: Intravenous only (faster onset than subcutaneous; oral is inappropriate in this emergency)
Monitoring and redosing:
- Recheck INR at 15-60 minutes after PCC administration, then serially every 6-8 hours for the first 24-48 hours 1
- If INR remains ≥1.4 at 24-48 hours: Give a second dose of vitamin K 10 mg IV 1
- If INR remains elevated despite repeat vitamin K, consider additional fresh frozen plasma (10-15 mL/kg) 1
Critical Considerations for Mechanical Valve Patients
Your patient presents a high-stakes balancing act between hemorrhagic and thromboembolic risk:
- Mechanical mitral valves carry the highest thromboembolic risk of all prosthetic valves (annual stroke risk 8-22% without anticoagulation)
- Despite this risk, immediate reversal is still indicated for intracerebral hemorrhage—the mortality from uncontrolled ICH outweighs short-term thrombotic risk
- The vitamin K dose remains 10 mg IV regardless of valve type; do not reduce the dose out of concern for thrombosis 1
Post-reversal anticoagulation strategy:
- Once hemorrhage is stabilized (typically 24-72 hours with stable repeat imaging), cautiously resume anticoagulation
- Bridge with unfractionated heparin (no bolus, lower target aPTT initially) before restarting warfarin 3
- Neurosurgical consultation should guide timing of anticoagulation resumption based on hemorrhage characteristics
Common Pitfalls to Avoid
Delaying vitamin K while waiting for PCC: Give both immediately—vitamin K takes 12-24 hours for full effect, so any delay prolongs the window of vulnerability 4
Using subcutaneous or oral vitamin K: IV route is mandatory for emergency reversal; subcutaneous absorption is unpredictable and oral is too slow 5
Giving inadequate vitamin K dose: Some clinicians give 5 mg, but guidelines specifically recommend 10 mg for intracranial hemorrhage 1
Failing to redose vitamin K if INR rebounds: Check INR serially and be prepared to give a second 10 mg dose at 24-48 hours 1
Assuming PCC alone is sufficient: Real-world data shows that 76.5% adherence to guideline-based therapy (PCC + vitamin K) versus 34.4% with suboptimal protocols directly correlates with improved outcomes 6
Supporting Evidence Quality
The recommendation is based on:
- 2016 Neurocritical Care Society/Society of Critical Care Medicine guidelines (most authoritative source for this specific scenario) 1
- 2020 ACC Expert Consensus confirms vitamin K should "always be given" when PCCs reverse VKAs 7
- FDA labeling for warfarin overdose supports 5-25 mg (rarely up to 50 mg) parenteral vitamin K for severe hemorrhage, but guideline-specific dosing for ICH is 10 mg 8
- Multiple observational studies demonstrate improved mortality with combined therapy 2, 9, 10
The evidence consistently supports 10 mg IV as the standard dose, with flexibility to redose based on INR response rather than giving higher initial doses.